http://investor.shareholder.com/biocryst/releases.cfm?sh_auth=0.0.0.ad1dcb691ef81696c0c02ea27e385165en-usShareholder.com RSS Feedhttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=763550Thu, 09 May 2013 14:00:00 GMThttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=763550BioCryst to Present at Two Upcoming Investor Conferenceshttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=762475Tue, 07 May 2013 10:06:00 GMThttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=762475BioCryst Provides Corporate Update and Reports First Quarter 2013 Financial Resultshttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=758330Tue, 23 Apr 2013 10:30:00 GMThttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=758330BioCryst to Announce First Quarter 2013 Financial Results May 7http://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=756697Tue, 16 Apr 2013 11:03:00 GMThttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=756697BioCryst Pharmaceuticals Completes Peramivir Type C Meetinghttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=752544Mon, 01 Apr 2013 10:12:00 GMThttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=752544BioCryst Pharmaceuticals Provides Update Regarding Peramivirhttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=750553Mon, 25 Mar 2013 10:05:00 GMThttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=750553BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX4161 for the Treatment of Hereditary Angioedemahttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=741149Tue, 19 Feb 2013 11:05:00 GMThttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=741149BioCryst Reports Fourth Quarter and Full Year 2012 Financial Resultshttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=738020Tue, 05 Feb 2013 18:00:00 GMThttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=738020BioCryst to Announce Fourth Quarter & 2012 Financial Results on February 19, 2013http://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=731108Wed, 02 Jan 2013 18:00:00 GMThttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=731108BioCryst to Present at J.P. Morgan Healthcare Conferencehttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=725543Fri, 07 Dec 2012 11:05:00 GMThttp://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=725543BioCryst Pharmaceuticals Announces Focused Corporate Strategy and Restructuring